OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis
Clinical trial NCT02062905 · COMPLETED
Trial details
- NCT number
- NCT02062905
- Sponsor
- Ocular Therapeutix, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-08-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.